K. Schatteman
Impact in
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
Papers in
- Oncology 6
- Peptidase Inhibition and Analysis 6
-
- Blood Coagulation and Thrombosis Mechanisms 6
- Co-authors
- Dirk Hendriks (12 shared papers)Simon Scharpé (8 shared papers)Filip Goossens (11 shared papers)Judith Leurs (5 shared papers)Hugo Neels (2 shared papers)Viveca Nerme (2 shared papers)Greet Vanhoof (6 shared papers)Petter Björquist (1 shared paper)
In The Last Decade
K. Schatteman
15 papers receiving 326 citations
Peers
Comparison fields: 5 of 53
- Hematology 189
- Internal Medicine 21
- Cancer Research 57
- Toxicology 12
- Genetics 31
Countries citing papers authored by K. Schatteman
This map shows the geographic impact of K. Schatteman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Schatteman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Schatteman more than expected).
Fields of papers citing papers by K. Schatteman
This network shows the impact of papers produced by K. Schatteman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Schatteman. The network helps show where K. Schatteman may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Schatteman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 68 | |
| 2 | 2000 | 45 | |
| 3 | 2003 | 39 | |
| 4 | 2001 | 38 | |
| 5 | 1996 | 36 | |
| 6 | 2004 | 27 | |
| 7 | 1999 | 23 | |
| 8 | 2002 | 22 | |
| 9 | 2001 | 14 | |
| 10 | 2001 | 10 | |
| 11 | 1997 | 7 | |
| 12 | 1997 | 6 | |
| 13 | Procarboxypeptidase U is expressed in human liver | 1997 | 5 |
| 14 | 2008 | 3 | |
| 15 | 2008 | 2 |
About K. Schatteman
K. Schatteman is a scholar working on Oncology, Hematology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience, having authored 15 papers that have together received 345 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Signaling Pathways in Disease (5 papers), Cardiac Arrhythmias and Treatments (2 papers), Biotin and Related Studies (2 papers), Diabetes Treatment and Management (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Hematology (189 citations), Internal Medicine (21 citations), Cancer Research (57 citations), Toxicology (12 citations) and Genetics (31 citations). K. Schatteman has collaborated with scholars based in Belgium, Brazil and Sweden. Frequent co-authors include Dirk Hendriks, Simon Scharpé, Filip Goossens, Judith Leurs, Hugo Neels, Viveca Nerme, Greet Vanhoof, Petter Björquist, Robert Verkerk and J. Wauters. Their work appears in journals such as Thrombosis and Haemostasis, Clinical Chemistry and Laboratory Medicine (CCLM), Clinical Chemistry, Advances in experimental medicine and biology and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.